{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:24:07Z","timestamp":1790421847916,"version":"4.1.0"},"reference-count":155,"publisher":"Informa UK Limited","issue":"9","license":[{"start":{"date-parts":[[2017,6,28]],"date-time":"2017-06-28T00:00:00Z","timestamp":1498608000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Biology"],"published-print":{"date-parts":[[2017,9,2]]},"DOI":"10.1080\/09553002.2017.1338782","type":"journal-article","created":{"date-parts":[[2017,6,28]],"date-time":"2017-06-28T13:04:14Z","timestamp":1498655054000},"page":"870-884","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":89,"title":["A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part II. Countermeasures for limited indications, internalized radionuclides, emesis, late effects, and agents demonstrating efficacy in large animals with or without FDA IND status"],"prefix":"10.1080","volume":"93","author":[{"given":"Vijay K.","family":"Singh","sequence":"first","affiliation":[{"name":"Division of Radioprotection, Department of Pharmacology and Molecular Therapeutics, F. Edward H\u00e9bert School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, USA;"},{"name":"Armed Forces Radiobiology Research Institute, Uniformed Services University of the Health Sciences, Bethesda, MD, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Garcia","sequence":"additional","affiliation":[{"name":"Division of Radioprotection, Department of Pharmacology and Molecular Therapeutics, F. Edward H\u00e9bert School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, USA;"},{"name":"Armed Forces Radiobiology Research Institute, Uniformed Services University of the Health Sciences, Bethesda, MD, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Seed","sequence":"additional","affiliation":[{"name":"Tech Micro Services, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2017,6,28]]},"reference":[{"key":"CIT0001","unstructured":"Aeolus Pharmaceuticals. 2012. Aeolus Pharmaceuticals announces AEOL 10150 reduces lung damage after Neupogen treatment following radiation exposure. Mission Viejo (CA). Available at: http:\/\/www.aolsrx.com\/news\/press-releases\/detail\/924\/aeolus-pharmaceuticals-announces-aeol-10150-reduces-lung [accessed 3 July 2014]."},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2016.04.016"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1080\/01635581.2010.509839"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1016\/0273-1177(89)90453-5"},{"key":"CIT0005","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1016\/S0021-9258(18)45614-1","volume":"262","author":"Akiyama T","year":"1987","journal-title":"J Biol Chem"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2006.01.013"},{"key":"CIT0007","unstructured":"American Thyroid Association. 2013. Nuclear radiation and the thyroid. Available at: http:\/\/www.thyroid.org\/wp-content\/uploads\/patients\/brochures\/NuclearRadiation_brochure.pdf [accessed 1 Sept 2016]."},{"key":"CIT0008","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1182\/blood.V77.6.1376.1376","volume":"77","author":"Atkinson K","year":"1991","journal-title":"Blood"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2012.5147"},{"key":"CIT0010","unstructured":"Beaulieu D. 2007. US government rejects Hollis-Eden\u2019s Neumune proposal [Online]. FirstWorld Pharma. Available at: http:\/\/www.firstwordpharma.com\/node\/112458#axzz4hMkBsGLh [accessed 17 May 2017]."},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2010.08.032"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1667\/RR1632.1"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1667\/RR2399.1"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1053\/sonc.2002.37349"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.11.5816"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1126\/science.1154986"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1667\/RR13330.1"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1079\/BJN20051640"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2013.772227"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1080\/09553000600568002"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1053\/srao.2002.31382"},{"key":"CIT0022","unstructured":"Cellerant Therapeutics. 2013. CLT-008 myeloid progenitor cells [Online]. Cellerant therapeutics; Available at: http:\/\/www.cellerant.com\/ [accessed 4 July 2016]."},{"key":"CIT0023","unstructured":"Centers for Disease Control and Prevention. 2016. Emergency preparedness and response. Available at: http:\/\/emergency.cdc.gov\/radiation\/countermeasures.asp [accessed 1 Sept 2016]."},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1016\/j.etp.2008.09.003"},{"key":"CIT0025","doi-asserted-by":"crossref","unstructured":"Clayton NP, Charpentier EJJ, LaCasse ER, Khan-Malek RC, Keutzer JM. 2016. Sargramostim significantly improved the mortality rate at Day 60 in a non-human primate model of hematopoietic acute radiation syndrome with minimal supportive care when administered 48\u2009h after total body irradiation. Poster presented at: 42nd Conference of the European Radiation Research Society; Amsterdam, Netherlands.","DOI":"10.1182\/blood.V128.22.2512.2512"},{"key":"CIT0026","unstructured":"Cleveland BioLabs Inc. 2016. Entolimod (CBLB502) biodefense. Cleveland BioLabs, Inc. Available at: http:\/\/www.cbiolabs.com\/ [accessed 10 June 2016]."},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2006.07.016"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.3109\/09553002.2013.770579"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-015-1042-9"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200161050-00012"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1177\/019262339902700113"},{"key":"CIT0032","unstructured":"Davies J. 2007. U.S. won\u2019t buy Hollis-Eden treatment for radiation. Union Turbine. Available at: http:\/\/legacy.sandiegouniontribune.com\/news\/business\/biotech\/20070317-9999-1b17hollis.html [accessed 17 May 2017]."},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1080\/09553000601132642"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1080\/09553000802317778"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1269\/jrr.07121"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2012.12.029"},{"key":"CIT0037","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1182\/blood.V82.10.3012.3012","volume":"82","author":"Farese AM","year":"1993","journal-title":"Blood"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1080\/095530099140258"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aal2408"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.12091"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1097\/HP.0b013e3182a4d967"},{"key":"CIT0042","unstructured":"Georges GE, Kuver RP, Jordan R, Aragon A, Yang Y, Lesnikova M, Lesnikov V, Sale GE, McDonald GB. 2012. Post-exposure oral 17,21-beclomethasone dipropionate (BDP) improves survival in a canine gastrointestinal acute radiation syndrome (GI-ARS) model. Poster presented at: 58th Annual Meeting of the Radiation Research Society; San Juan (PR)."},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.1667\/RR13802.1"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1093\/jrr\/rrs001"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1667\/RR14248.1"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1667\/RR1367.1"},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-015-0136-3"},{"key":"CIT0048","doi-asserted-by":"publisher","DOI":"10.1186\/1756-8722-7-31"},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23770"},{"key":"CIT0050","doi-asserted-by":"publisher","DOI":"10.1667\/RR13962.1"},{"key":"CIT0051","doi-asserted-by":"publisher","DOI":"10.1016\/j.radmeas.2007.05.011"},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.1093\/jrr\/rrs060"},{"key":"CIT0053","first-page":"3101","volume":"27","author":"Gridley DS","year":"2007","journal-title":"Anticancer Res"},{"key":"CIT0054","first-page":"801","volume":"60","author":"Gudkov SV","year":"2015","journal-title":"Biofizika"},{"key":"CIT0055","unstructured":"Gupta S. 2013. FDA advisory committee meeting: Study drug Leukine. Available at: http:\/\/www.fda.gov\/downloads\/advisorycommittees\/committeesmeetingmaterials\/drugs\/medicalimagingdrugsadvisorycommittee\/ucm350156.pdf [accessed 2 Oct 2016]."},{"key":"CIT0056","doi-asserted-by":"publisher","DOI":"10.1667\/RR3326.1"},{"key":"CIT0057","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1182\/blood.V76.3.523.523","volume":"76","author":"Hammond WP","year":"1990","journal-title":"Blood"},{"key":"CIT0058","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-014-3074-x"},{"key":"CIT0059","unstructured":"Health and Human Services. 2016. HHS enhances nation\u2019s health preparedness for radiological threats. Available at: https:\/\/www.hhs.gov\/about\/news\/2016\/10\/06\/hhs-enhances-nation-s-health-preparedness-radiological-threats.html [accessed 20 Oct 2016]."},{"key":"CIT0060","unstructured":"Henry M, Jackson Foundation for the Advancement of Military Medicine Inc. Kumar KS, Srinivasan V, Seed TM. 2004. Radiation protection by gamma-tocotrienol. PCT\/US2002\/004522; WO\/2004\/086412."},{"key":"CIT0061","first-page":"708","volume":"19","author":"Huang R","year":"2002","journal-title":"Sheng Wu Yi Xue Gong Cheng Xue Za Zhi"},{"key":"CIT0062","unstructured":"Humanetics Pharmaceuticals. 2016. BIO 300: development programs. Edina (MN): Humanetics Pharmaceuticals. Available at: http:\/\/humanetics.a03.neon.ittrium.com\/development-programs [accessed 5 July 2016]."},{"key":"CIT0063","doi-asserted-by":"publisher","DOI":"10.1097\/00152193-200502000-00041"},{"key":"CIT0064","unstructured":"International Atomic Energy Agency (IAEA). 1988. The radiological accident in Goi\u00e2nia. Available at: http:\/\/www-pub.iaea.org\/MTCD\/Publications\/PDF\/Pub815_web.pdf [accessed 2 Oct 2016]."},{"key":"CIT0065","unstructured":"International Atomic Energy Agency (IAEA). 1990. The radiological accident in San Salvador. Available at: http:\/\/www-pub.iaea.org\/books\/IAEABooks\/3718\/The-Radiological-Accident-in-San-Salvador [accessed 20 Feb 2014]."},{"key":"CIT0066","unstructured":"International Atomic Energy Agency (IAEA). 1993. The radiological accident in Soreq. Available at: http:\/\/www-pub.iaea.org\/books\/IAEABooks\/3798\/The-Radiological-Accident-in-Soreq [accessed 20 Feb 2014]."},{"key":"CIT0067","unstructured":"International Atomic Energy Agency (IAEA). 1996. The radiological accident at the irradiation facility in Nesvizh. Available at: http:\/\/www-pub.iaea.org\/books\/IAEABooks\/4712\/The-Radiological-Accident-at-the-Irradiation-Facility-in-Nesvizh [accessed 10 Feb 2014]."},{"key":"CIT0068","doi-asserted-by":"publisher","DOI":"10.1667\/RR1911.1"},{"key":"CIT0069","doi-asserted-by":"publisher","DOI":"10.1667\/RR2421.1"},{"key":"CIT0070","doi-asserted-by":"publisher","DOI":"10.1097\/HP.0b013e31826386ef"},{"key":"CIT0071","doi-asserted-by":"publisher","DOI":"10.2217\/fon.14.175"},{"key":"CIT0072","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0058355"},{"key":"CIT0073","first-page":"23","volume":"9","author":"Karacetin D","year":"2004","journal-title":"BUON"},{"key":"CIT0074","doi-asserted-by":"publisher","DOI":"10.2174\/138920112802273308"},{"key":"CIT0075","volume-title":"Triage of irradiated personnel. Armed forces radiobiology research institute workshop","author":"Kehlet RA","year":"1996"},{"key":"CIT0076","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/68.6.1418S"},{"key":"CIT0077","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2012.08.017"},{"key":"CIT0078","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.112.196071"},{"key":"CIT0079","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0135388"},{"key":"CIT0080","doi-asserted-by":"publisher","DOI":"10.1002\/bio.808"},{"key":"CIT0081","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2013.03.009"},{"key":"CIT0082","unstructured":"Kumar KS, Papas A, Seed TM, Srinivasan V. 2006. Radiation protection by gamma-tocotrienol. USA Patent application PCT\/US2004\/00452."},{"key":"CIT0083","doi-asserted-by":"publisher","DOI":"10.1002\/jat.904"},{"key":"CIT0084","doi-asserted-by":"publisher","DOI":"10.1038\/ijos.2013.93"},{"key":"CIT0085","doi-asserted-by":"publisher","DOI":"10.1269\/jrr.07071"},{"key":"CIT0086","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1182\/blood.V77.10.2154.2154","volume":"77","author":"Lord BI","year":"1991","journal-title":"Blood"},{"key":"CIT0087","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2000.tb05452.x"},{"key":"CIT0088","first-page":"1","volume":"90","author":"MacVittie TJ","year":"1991","journal-title":"Behring Inst Mitt"},{"key":"CIT0089","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1182\/blood.V95.3.837.003k08_837_845","volume":"95","author":"MacVittie TJ","year":"2000","journal-title":"Blood"},{"key":"CIT0090","doi-asserted-by":"publisher","DOI":"10.3109\/09553002.2011.583315"},{"key":"CIT0091","doi-asserted-by":"publisher","DOI":"10.1016\/0090-1229(90)90047-T"},{"key":"CIT0092","first-page":"344","volume":"16","author":"Monroy RL","year":"1988","journal-title":"Exp Hematol"},{"key":"CIT0093","doi-asserted-by":"publisher","DOI":"10.1667\/RR14110.1"},{"key":"CIT0094","doi-asserted-by":"publisher","DOI":"10.3816\/CBC.2002.n.030"},{"key":"CIT0095","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703356"},{"key":"CIT0096","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1182\/blood.V83.7.1963.1963","volume":"83","author":"Nash RA","year":"1994","journal-title":"Blood"},{"key":"CIT0097","unstructured":"National Institute of Allergic and Infectious Diseases. 2015. Pegfilgrastim approved for treating acute radiation syndrome. Available at: https:\/\/www.niaid.nih.gov\/topics\/radnuc\/Pages\/pegfilgrastim.aspx [accessed 18 Aug 2016]."},{"key":"CIT0098","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.7.2565"},{"key":"CIT0099","unstructured":"Neumedicines. 2014. HemaMax\u2122 (rHuIL-12) for acute radiation syndrome. Pasadena, CA: Neumedicines. Available at: http:\/\/www.neumedicines.com\/ [accessed 27 Oct 2014]."},{"key":"CIT0100","doi-asserted-by":"publisher","DOI":"10.1080\/09553009214551281"},{"key":"CIT0101","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2004.09.085"},{"key":"CIT0102","first-page":"70","volume":"7","author":"Orrell RW.","year":"2006","journal-title":"Curr Opin Investig Drugs"},{"key":"CIT0103","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2009.04.005"},{"key":"CIT0104","doi-asserted-by":"publisher","DOI":"10.1007\/BF01878150"},{"key":"CIT0105","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-016-1950-0"},{"key":"CIT0106","doi-asserted-by":"publisher","DOI":"10.3109\/09553000903419965"},{"key":"CIT0107","doi-asserted-by":"publisher","DOI":"10.1667\/RR2806.1"},{"key":"CIT0108","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910620321"},{"key":"CIT0109","doi-asserted-by":"publisher","DOI":"10.1002\/stem.140452"},{"key":"CIT0110","doi-asserted-by":"publisher","DOI":"10.1211\/jpp.60.7.0001"},{"key":"CIT0111","doi-asserted-by":"publisher","DOI":"10.1097\/HP.0000000000000090"},{"key":"CIT0112","unstructured":"Sanofi-aventis U.S. LLC. 2013. Leukine. Available at: http:\/\/products.sanofi.us\/Leukine\/Leukine.html [accessed 20 Oct 2016]."},{"key":"CIT0113","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2.3.479"},{"key":"CIT0114","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(96)00316-4"},{"key":"CIT0115","doi-asserted-by":"publisher","DOI":"10.1097\/01.HP.0000175153.19745.25"},{"key":"CIT0116","doi-asserted-by":"publisher","DOI":"10.3109\/09553002.2014.899450"},{"key":"CIT0117","first-page":"86","volume":"90","author":"Selig C","year":"1991","journal-title":"Behring Inst Mitt"},{"key":"CIT0118","doi-asserted-by":"publisher","DOI":"10.1667\/RR2894.1"},{"key":"CIT0119","doi-asserted-by":"publisher","DOI":"10.3109\/09553002.2012.652726"},{"key":"CIT0120","doi-asserted-by":"publisher","DOI":"10.1093\/rpd\/ncw223"},{"key":"CIT0121","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17050663"},{"key":"CIT0122","doi-asserted-by":"publisher","DOI":"10.1667\/RR14127.1"},{"key":"CIT0123","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2014.08.003"},{"key":"CIT0124","doi-asserted-by":"publisher","DOI":"10.1080\/17460441.2017.1323863"},{"key":"CIT0125","doi-asserted-by":"publisher","DOI":"10.1080\/13543776.2016.1231805"},{"key":"CIT0126","doi-asserted-by":"publisher","DOI":"10.1097\/HP.0000000000000279"},{"key":"CIT0127","doi-asserted-by":"publisher","DOI":"10.1080\/08923970500416707"},{"key":"CIT0128","unstructured":"Soligenix Inc. 2016. OrbeShield\u2122 for gastrointestinal acute radiation syndrome (GI ARS). Princeton, NJ: Soligenix, Inc. Available at: http:\/\/www.soligenix.com\/pipeline\/vaccinesbiodefense\/orbeshield-for-gastrointestinal-acute-radiation-syndrome-gi-ars\/ [accessed 10 July 2016]."},{"key":"CIT0129","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2011.11.038"},{"key":"CIT0130","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2006.12.005"},{"key":"CIT0131","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2006.07.005"},{"key":"CIT0132","doi-asserted-by":"publisher","DOI":"10.1088\/0952-4746\/30\/4\/004"},{"key":"CIT0133","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2013.08.011"},{"key":"CIT0134","doi-asserted-by":"publisher","DOI":"10.1269\/jrr.11191"},{"key":"CIT0135","doi-asserted-by":"publisher","DOI":"10.1186\/1748-717X-7-6"},{"key":"CIT0136","doi-asserted-by":"publisher","DOI":"10.1080\/01635581.2010.509841"},{"key":"CIT0137","doi-asserted-by":"publisher","DOI":"10.1667\/RR0751.1"},{"key":"CIT0138","first-page":"883","volume":"17","author":"Tanikawa S","year":"1989","journal-title":"Exp Hematol"},{"key":"CIT0139","unstructured":"The Radiation Emergency Assistance Center\/Training Site. 2013. The medical aspects of radiation incidents. Available at: https:\/\/orise.orau.gov\/files\/reacts\/medical-aspects-of-radiation-incidents.pdf [accessed 28 Oct 2016]."},{"key":"CIT0140","unstructured":"U.S. Department of Health & Human Services. 2013. HHS boosts stockpile of products to treat acute radiation syndrome. Available at: http:\/\/www.hhs.gov\/news\/press\/2013pres\/09\/20130926a.html [accessed 12 Feb 2014]."},{"key":"CIT0141","unstructured":"U.S. Food and Drug Administration. 2015. FDA approves Neupogen for treatment of patients with radiation-induced myelosuppression following a radiological\/nuclear incident. Silver Spring (MD): U.S. Food and Drug Administration. Available at: http:\/\/www.fda.gov\/EmergencyPreparedness\/Counterterrorism\/MedicalCountermeasures\/AboutMCMi\/ucm443245.htm [accessed 6 July 2016]."},{"key":"CIT0142","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.12169"},{"key":"CIT0143","doi-asserted-by":"publisher","DOI":"10.2174\/1389557043403387"},{"key":"CIT0144","first-page":"2","volume":"21","author":"van der Vijgh WJ","year":"1994","journal-title":"Semin Oncol"},{"key":"CIT0145","first-page":"168","volume":"36","author":"Vasin MV","year":"1996","journal-title":"Radiats Biol Radioecol"},{"key":"CIT0146","doi-asserted-by":"publisher","DOI":"10.1093\/jrr\/rru046"},{"key":"CIT0147","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1182\/blood.V77.11.2364.2364","volume":"77","author":"Waddick KG","year":"1991","journal-title":"Blood"},{"key":"CIT0148","first-page":"1349","volume":"15","author":"Wasserman TH","year":"2001","journal-title":"Oncology (Williston Park, NY)"},{"key":"CIT0149","doi-asserted-by":"publisher","DOI":"10.1097\/HP.0000000000000198"},{"key":"CIT0150","doi-asserted-by":"publisher","DOI":"10.1016\/S0192-0561(99)00059-4"},{"key":"CIT0151","doi-asserted-by":"publisher","DOI":"10.1081\/IPH-51289"},{"key":"CIT0152","doi-asserted-by":"publisher","DOI":"10.1081\/IPH-120016038"},{"key":"CIT0153","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2006.09.002"},{"key":"CIT0154","doi-asserted-by":"publisher","DOI":"10.1097\/PEC.0b013e3182a380b8"},{"key":"CIT0155","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2011.08.005"}],"container-title":["International Journal of Radiation Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/09553002.2017.1338782","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/09553002.2017.1338782","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T03:20:43Z","timestamp":1659151243000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/09553002.2017.1338782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,28]]},"references-count":155,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9,2]]}},"alternative-id":["10.1080\/09553002.2017.1338782"],"URL":"https:\/\/doi.org\/10.1080\/09553002.2017.1338782","relation":{},"ISSN":["0955-3002","1362-3095"],"issn-type":[{"value":"0955-3002","type":"print"},{"value":"1362-3095","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,28]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=irab20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=irab20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2017-01-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-05-18","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-05-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-06-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}